Using the impact of pneumococcal vaccines on nasopharyngeal carriage to aid licensing and vaccine implementation; A Pneumocarr meeting report March 27-28, 2012, Geneva

Vaccine

Volumn 32, Issue 1, 2013, Pages 146-152

  Goldblatt, David ^a   Ramakrishnan, Meena ^b   O'Brien, Katherine ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Independent Consultant   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Licensing pathways; Pneumococcal carriage; Pneumococcal vaccines

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; BACTERIAL COLONIZATION; CONSENSUS; CONSULTATION; DRUG APPROVAL; DRUG EFFECT; DRUG INDUSTRY; HEALTH IMPACT ASSESSMENT; LICENSING; NONHUMAN; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; VACCINATION;

LICENSING PATHWAYS; PNEUMOCOCCAL CARRIAGE; PNEUMOCOCCAL VACCINES;

CARRIER STATE; HUMANS; LICENSURE; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PUBLIC HEALTH; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VACCINES, CONJUGATE;

EID: 84891940496     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.06.040     Document Type: Article

References (19)

1. Expert Committee on Biological Standardization Recommendations to assure the quality, safety and efficacy of pneumococcal conjugate vaccines-proposed replacement of TRS 927 Annex 2 2009, World Health Organization, Available at: http://www.who.int/biologicals/areas/vaccines/pneumo/Pneumo_final_23APRIL_2010.pdf.
2. Simell B., Auranen K.J., Käyhty H., Dagan R., O'Brien K.L. The fundamental link between pneumococcal carriage and disease. Expert Review of Vaccines 2012, 11(7):841-855. PMID: 22913260.
3. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR 2005, 54(36):893-897.
4. O'Brien K.L., Nohynek H., et al. Report from a WHO working group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatric Infectious Disease Journal 2003, 22:133-140.
5. Auranen K.J., Rinta-Kokko H., Goldblatt D., Nohynek H., O'Brien K., Satzke C., Simell B., Tanskanen A., Käyhty H. Colonisation enpoints in Streptococcus pneumoniae vaccine trials. Vaccine 2013, in press.
6. Auranen K.J., Rinta-Kokko H., Goldblatt D., Nohynek H., O'Brien K., Satzke C., Simell B., Tanskanen A., Käyhty H. Design questions for Streptococcus pneumoniae vaccine trials with a colonization enpoint. Vaccine 2013, PII:S0264-410X(13)00936-5; doi:10.1016/j.vaccine.2013.06.105.
7. Cohen R., Levy C., Bingen E., Koskas M., Nave I., Varon E. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media. Pediatric Infectious Disease Journal 2012, 31(3):297-301.
8. Dagan R., Patterson S., Juergens C., et al. The efficacy of the 13-valent pneumococcal conjugate vaccine (PCV13) additional serotypes on nasopharyngeal colonization: a randomized double-blind pediatric trial. International Symposium on Pneumococci and Pneumococcal Diseases, March 11-15 2012.
9. European Medicines Agency Qualification of novel methodologies for drug development 2012, Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000319.jsp&mid=WC0b01ac0580022bb0. (Accessed 20.06.12).
10. Simell B., Auranen K.J., Käyhty H., Dagan R., O'Brien K.L. The fundamental link between pneumococcal carriage and disease. Expert Review of Vaccines 2012, 11(7):841-855. PMID: 22913260.
11. Mbelle N., Huebner R.E., Wasas A.D., Kimura A., Chang I., Klugman KP Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. Journal of Infectious Diseases 1999, 180(4):1171-1176.
12. Cheung Y.B., Zaman S.M., Nsekpong E.D., et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings. Pediatric Infectious Disease Journal 2009, 28(11):990-995.
13. O'Brien K.L., Millar E.V., Zell E.R., et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. Journal of Infectious Diseases 2007, 196(8):1211-1220.
14. Prymula R., Kriz P., Kaliskova E., Pascal T., Poolman J., Schuerman L. Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age. Vaccine 2009, 28(1):71-78.
15. Kilpi T.M., Syrjänen R., Palmu A., et al. Parallel evaluation of the effect of a 7-valent pneumococcal conjugate vaccine (pncCRM) on pneumococcal carriage and acute otitis media. Presented at: 19th Annual Meeting of the European Society for the Pediatric Infectious Diseases (ESPID) 2001.
16. Nohynek H., Mäkelä P.H., Lucero M.G., et al. The impact of 11-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae in Philippine children. Presented at: 6th International Symposium on Pneumococci and Pneumococcal Diseases 2008.
17. Saez-Llorens X., Wong D., Rodriques M., et al. Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PhiD-CV) on nasopharyngeal bacterial carriage in Panamian children. Presented at: 7th World Society for Pediatric Infectious Diseases (WSPID) 2011.
18. Dagan R., Givon-Lavi N., Zamir O., et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. Journal of Infectious Diseases 2002, 185(7):927-936.
19. Auranen K., Käyhty H., Dagan R., Goldblatt D., O'Brien K., Scott A., Antonio M., Lucero M., Klugman K.P., Madhi S., Mulholland K. Case for carriage. Vaccine 2013, 10.1016/j.vaccine.2013.11.046.